lysergic acid diethylamide and Depression studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.

Research Excerpts

Excerpt	Relevance	Reference
"Recently, there has been interest in lysergic acid diethylamide (LSD) and psilocybin for depression, anxiety and fear of death in terminal illness."	8.98	Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? ( Johnson, MI; Whelan, A, 2018)
"Our search revealed 12 eligible studies (n = 257; 124 healthy participants, and 133 patients with mood disorders), with data from randomized controlled trials involving psilocybin (n = 8), lysergic acid diethylamide ([LSD]; n = 3), and ayahuasca (n = 1)."	5.12	Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. ( de Manincor, M; Galvão-Coelho, NL; Gonzalez, M; Marx, W; Perkins, D; Sarris, J; Sinclair, J, 2021)
"Recently, there has been interest in lysergic acid diethylamide (LSD) and psilocybin for depression, anxiety and fear of death in terminal illness."	4.98	Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? ( Johnson, MI; Whelan, A, 2018)
"Psychedelic therapy shows promise for Major Depressive Disorder, especially when treatment-resistant, as well as life-threatening illness distress."	3.01	Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. ( Cleare, AJ; Ko, K; Kopra, EI; Rucker, JJ, 2023)
"psilocybin, LSD) in treating cancer-related psychiatric distress."	2.58	Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. ( Ross, S, 2018)
"Psilocybin was the most commonly used microdose substances in our sample (85%) and we identified diverse microdose practices with regard to dosage, frequency, and the practice of stacking which involves combining psilocybin with non-psychedelic substances such as Lion's Mane mushrooms, chocolate, and niacin."	1.62	Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. ( Bourzat, F; Harvey, K; Kryskow, P; Kuypers, KPC; Polito, V; Rootman, JM; Santos-Brault, E; Stamets, P; Walsh, Z, 2021)
" This paper examines microdosing motivations, dosing practices, perceived short-term benefits, unwanted effects, and harm reduction practices."	1.56	Microdosing psychedelics: Motivations, subjective effects and harm reduction. ( Amada, N; Jungaberle, H; Klein, M; Lea, T; Schecke, H, 2020)

Timeframe	Studies, this research(%)	All Research%
pre-1990	52 (70.27)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (2.70)	29.6817
2010's	10 (13.51)	24.3611
2020's	10 (13.51)	2.80

Authors	Studies
Rootman, JM	1
Kryskow, P	1
Harvey, K	1
Stamets, P	1
Santos-Brault, E	1
Kuypers, KPC	2
Polito, V	1
Bourzat, F	1
Walsh, Z	1
Jaster, AM	1
Elder, H	1
Marsh, SA	1
de la Fuente Revenga, M	1
Negus, SS	1
González-Maeso, J	1
Yang, KH	1
Han, BH	1
Palamar, JJ	1
Willyard, C	1
Ko, K	1
Kopra, EI	1
Cleare, AJ	1
Rucker, JJ	1
Pilozzi, A	1
Foster, S	1
Mischoulon, D	1
Fava, M	1
Huang, X	1
Harris, E	1
Lea, T	1
Amada, N	1
Jungaberle, H	1
Schecke, H	1
Klein, M	1
Galvão-Coelho, NL	1
Marx, W	1
Gonzalez, M	1
Sinclair, J	1
de Manincor, M	1
Perkins, D	1
Sarris, J	1
Tullis, P	1
Bayat, M	1
Whelan, A	1
Johnson, MI	1
Ross, S	1
Weigmann, K	1
Kvam, TM	1
Stewart, LH	1
Andreassen, OA	1
Anderson, T	1
Petranker, R	1
Rosenbaum, D	1
Weissman, CR	1
Dinh-Williams, LA	1
Hui, K	1
Hapke, E	1
Farb, NAS	1
Buchborn, T	1
Schröder, H	1
Höllt, V	1
Grecksch, G	1
Nichols, DE	1
Johnson, MW	1
Nichols, CD	1
Nichols, D	1
Lerner, AG	1
Shufman, E	1
Kodesh, A	1
Kretzmer, G	1
Sigal, M	1
HOFFER, A	2
OSMOND, H	2
LEHMANN, HE	1
BAN, TA	1
KENNA, JC	2
SEDMAN, G	2
LISS, L	1
SOLZE, DA	1
FISCHER, R	1
ROSENTHAL, SH	1
Knudsen, K	1
SAVAGE, C	2
Diamond, GM	1
Izzard, MC	1
Kedar, T	1
Hutlzer, A	1
Mell, H	1
Ray, OS	1
Bivens, LW	1
Middlefell, R	1
Frosch, WA	1
Robbins, E	1
Robbins, L	1
Stern, M	1
Halleck, SL	1
Smythies, JR	1
Ditman, KS	1
Tietz, W	1
Prince, BS	1
Forgy, E	1
Moss, T	1
Bliss, EL	1
Willner, P	1
Lake, F	1
Natale, M	1
Dahlberg, CC	1
Jaffe, J	1
Ogren, SO	1
Fuxe, K	1
Agnati, LF	1
Gustafsson, JA	1
Jonsson, G	1
Holm, AC	1
Boyd, P	1
Linken, A	1
Rosen, DH	1
Hoffman, AM	1
Grof, S	2
Goodman, LE	1
Richards, WA	1
Kurland, AA	2
Rozynko, VV	1
Stein, KB	1
Shagass, C	1
Salzman, C	1
Lieff, J	1
Kochansky, GE	1
Shader, RI	1
Fink, M	1
Remschmidt, H	1
Alexander, L	1
Lienert, GA	1
Krauth, J	1
Stone, WN	1
Hofling, CK	1
Winslow, WW	1
Rysánek, K	1
Waltzer, H	1
Teicher, JD	1
Denson, R	2
Bowers, M	1
Chipman, A	1
Schwartz, A	1
Dann, OT	1
Pahnke, WN	1
Unger, S	1
Brauer, R	1
Harrow, M	1
Tucker, GJ	1
Johnson, FG	1
Voelkel, A	1
Muller, DJ	1
Meltzer, H	1
Hekimian, LJ	1
Gershon, S	1
Pöldinger, W	1
Edison, GR	1
Ross, M	1
van Ree, F	1

Trial			Phase	Enrollment	Study Type	Start Date	Status
Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life[NCT05403086]			Phase 2	100 participants (Anticipated)	Interventional	2024-01-14	Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Journal of affective disorders, 2023, 02-01, Volume: 322 Topics: Depression; Depressive Disorder, Major; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybi	2023
A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression. International journal of molecular sciences, 2023, Aug-07, Volume: 24, Issue:15 Topics: Alzheimer Disease; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Serotonin	2023
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. Psychopharmacology, 2021, Volume: 238, Issue:2 Topics: Affect; Banisteriopsis; Depression; Depressive Disorder, Major; Double-Blind Method; Hallucinogens;	2021
[Classic psychedelic drugs and their potential therapeutic effect]. Ugeskrift for laeger, 2017, Sep-11, Volume: 179, Issue:37 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cluster Headache; Depression; Hallucinogens; Hu	2017
Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? Pain management, 2018, Volume: 8, Issue:3 Topics: Anxiety; Chronic Pain; Depression; Humans; Lysergic Acid Diethylamide; Pain; Psilocybin; Serotonin R	2018
Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. International review of psychiatry (Abingdon, England), 2018, Volume: 30, Issue:4 Topics: Anxiety; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin; Serot	2018
Psychedelic drugs in the treatment of anxiety, depression and addiction. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2018, 11-13, Volume: 138, Issue:18 Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Hallucinogens; Humans; Lysergic Acid Di	2018
Psychedelics as Medicines: An Emerging New Paradigm. Clinical pharmacology and therapeutics, 2017, Volume: 101, Issue:2 Topics: Anxiety; Brain; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Hallucinogen	2017
Electrophysiological studies of psychiatric problems. Revue canadienne de biologie, 1972, Volume: 31 Topics: Age Factors; Attention; Delirium; Depression; Down Syndrome; Electrophysiology; Evoked Potentials; H	1972
CNS effects of convulsive therapy: significance for a theory of depressive psychosis. Proceedings of the annual meeting of the American Psychopathological Association, 1972, Volume: 60 Topics: Alpha Rhythm; Amobarbital; Antidepressive Agents; Bipolar Disorder; Brain; Depression; Electroconvul	1972
[Hashish and LSD. Physical and mental effects. 2]. Medizinische Klinik, 1972, Jun-02, Volume: 67, Issue:22 Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Anxiety; Cannabis; Carcinogens; Chro	1972
Drug therapy. Progress in neurology and psychiatry, 1968, Volume: 23 Topics: Amphetamine; Animals; Antidepressive Agents; Bipolar Disorder; Butyrophenones; Chlorprothixene; Clin	1968
[Relation of monoamines to mental disorders]. Activitas nervosa superior, 1970, Volume: 12, Issue:2 Topics: Amines; Animals; Bipolar Disorder; Catecholamines; Central Nervous System; Depression; Dihydroxyphen	1970

Article	Year
The effect of psychotomimetics on therapist--patient matching of speech "rhythms". Journal of communication disorders, 1979, Volume: 12, Issue:1 Topics: Adult; Clinical Trials as Topic; Communication; Depression; Dextroamphetamine; Double-Blind Method;	1979
LSD-assisted psychotherapy in patients with terminal cancer. International pharmacopsychiatry, 1973, Volume: 8, Issue:3 Topics: Adult; Aged; Anxiety; Attitude to Death; Clinical Trials as Topic; Depression; Female; Humans; Lyser	1973
Drug therapy. Progress in neurology and psychiatry, 1968, Volume: 23 Topics: Amphetamine; Animals; Antidepressive Agents; Bipolar Disorder; Butyrophenones; Chlorprothixene; Clin	1968
Lysergide in the treatment of neurosis. (A report of two cases). Diseases of the nervous system, 1966, Volume: 27, Issue:8 Topics: Adult; Amobarbital; Antisocial Personality Disorder; Anxiety Disorders; Clinical Trials as Topic; De	1966

lysergic acid diethylamide and Depression

Research Excerpts

Research

Studies (74)

Authors

Clinical Trials (1)

Trial Overview

Reviews

Trials

Other Studies

Article	Year
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. Scientific reports, 2021, 11-18, Volume: 11, Issue:1 Topics: Adolescent; Adult; Anxiety; Cognition; Cross-Sectional Studies; Depression; Female; Hallucinogens; H	2021
Effects of the 5-HT Psychopharmacology, 2022, Volume: 239, Issue:6 Topics: Animals; Depression; Fluorobenzenes; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Mice; Phe	2022
Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults. Addictive behaviors, 2022, Volume: 132 Topics: Adult; Depression; Depressive Disorder, Major; Hallucinogens; Humans; Lysergic Acid Diethylamide; N-	2022
Psychedelic drugs take on depression. Nature, 2022, Volume: 608, Issue:7924 Topics: Depression; Hallucinogens; Lysergic Acid Diethylamide; Psilocybin	2022
LSD Use Increasing More Among People With Depression. JAMA, 2023, 11-14, Volume: 330, Issue:18 Topics: Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Substance-Related Disorders	2023
Microdosing psychedelics: Motivations, subjective effects and harm reduction. The International journal on drug policy, 2020, Volume: 75 Topics: Adult; Anxiety; Depression; Dose-Response Relationship, Drug; Female; Hallucinogens; Harm Reduction;	2020
How ecstasy and psilocybin are shaking up psychiatry. Nature, 2021, Volume: 589, Issue:7843 Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resista	2021
Lucy in the sky with ketamine: Psychoactive drugs have potential for a major breakthrough in treating depression. EMBO reports, 2018, Volume: 19, Issue:11 Topics: Antidepressive Agents; Depression; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Off-	2018
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology, 2019, Volume: 236, Issue:2 Topics: Adult; Anxiety; Creativity; Depression; Dose-Response Relationship, Drug; Emotions; Female; Hallucin	2019
Psychedelic medicine: The biology underlying the persisting psychedelic effects. Medical hypotheses, 2019, Volume: 125 Topics: Animals; Banisteriopsis; Cognition; Consciousness; Depression; Diet; Hallucinogens; Humans; Life Sty	2019
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:6 Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Depression; Disease Models, An	2014
Legal highs: the dark side of medicinal chemistry. Nature, 2011, Jan-06, Volume: 469, Issue:7328 Topics: Amphetamines; Animals; Depression; Designer Drugs; Drug Design; Electronic Mail; Hallucinogens; Huma	2011
LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report. The Israel journal of psychiatry and related sciences, 2002, Volume: 39, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Depression; Hallucinations; Hallucinogens; Humans; Lysergic Aci	2002
A QUESTION OF INSIGHT. Diseases of the nervous system, 1963, Volume: 24 Topics: Anxiety; Anxiety Disorders; Bipolar Disorder; Depression; Humans; Hysteria; Lysergic Acid Diethylami	1963
MALVARIA: A NEW PSYCHIATRIC DISEASE. Acta psychiatrica Scandinavica, 1963, Volume: 39, Issue:2 Topics: Alcoholism; Antidepressive Agents; Antisocial Personality Disorder; Child; Chromatography; Classific	1963
NOTES FROM THE LOG-BOOK OF A PSYCHOPHARMACOLOGICAL RESEARCH UNIT I. Canadian Psychiatric Association journal, 1964, Volume: 9 Topics: Amobarbital; Behavior; Books; Chlordiazepoxide; Depression; Dextroamphetamine; Electroconvulsive The	1964
THE SUBJECTIVE EXPERIENCE OF TIME DURING LYSERGIC ACID DIETHYLAMIDE (LSD-25) INTOXICATION. Psychopharmacologia, 1964, Mar-11, Volume: 5 Topics: Bipolar Disorder; Depression; Depressive Disorder; Humans; Hysteria; Lysergic Acid Diethylamide; Neu	1964
THE HISTOMORPHOLOGY OF EXPERIMENTAL EXCITATION. Neurology, 1964, Volume: 14 Topics: Acridines; Coloring Agents; Depression; Depressive Disorder; Hippocampus; Histology; Lysergic Acid D	1964
PERSISTENT HALLUCINOSIS FOLLOWING REPEATED ADMINISTRATION OF HALLUCINOGENIC DRUGS. The American journal of psychiatry, 1964, Volume: 121 Topics: Adolescent; Animals; Anxiety; Cats; Depression; Drug Therapy; Electroretinography; Hallucinations; H	1964
THE USE OF LSD-25 AS A DIAGNOSTIC AID IN DOUBTFUL CASES OF SCHIZOPHRENIA. The British journal of psychiatry : the journal of mental science, 1965, Volume: 111 Topics: Depression; Depressive Disorder; Diagnosis; Drug Therapy; Humans; Lysergic Acid Diethylamide; Person	1965
HOMICIDE AFTER TREATMENT WITH LYSERGIC ACID DIETHYLAMIDE. Acta psychiatrica Scandinavica, 1964, Volume: 39, Issue:S180 Topics: Antisocial Personality Disorder; Depression; Depressive Disorder; Drug Therapy; Homicide; Humans; Ly	1964
Lysergic acid diethylamide; a clinical-psychological study. The American journal of psychiatry, 1952, Volume: 108, Issue:12 Topics: Biomedical Research; Depression; Depressive Disorder; Ergot Alkaloids; Lysergic Acid Diethylamide; M	1952
Psychological symptoms and drug use severity among Israeli adolescents presenting for outpatient drug abuse treatment. Journal of adolescence, 2005, Volume: 28, Issue:4 Topics: Adolescent; Ambulatory Care; Attention Deficit and Disruptive Behavior Disorders; Depression; Female	2005
Performance as a function of drug, dose, and level of training. Psychopharmacologia, 1966, Volume: 10, Issue:2 Topics: Achievement; Animals; Auditory Perception; Behavior, Animal; Chlorpromazine; Depression; Humans; Lys	1966
The effects of LSD on body sway suggestibility in a group of hospital patients. The British journal of psychiatry : the journal of mental science, 1967, Volume: 113, Issue:496 Topics: Adult; Depression; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Neurotic Disorders	1967
Motivation for self-administration of LSD. The Psychiatric quarterly, 1967, Volume: 41, Issue:1 Topics: Anxiety; Behavior; Depression; Humans; Love; Lysergic Acid Diethylamide; Motivation; Personality; Su	1967
LSD. The Medical letter on drugs and therapeutics, 1967, Jan-13, Volume: 9, Issue:1 Topics: Body Image; Cannabis; Chlorpromazine; Depersonalization; Depression; Drug Tolerance; Euphoria; Hallu	1967
Psychiatric treatment of the alienated college student. The American journal of psychiatry, 1967, Volume: 124, Issue:5 Topics: Attention; Cannabis; Depression; Female; Humans; Interpersonal Relations; Lysergic Acid Diethylamide	1967
Research strategies in schizophrenia. Nature, 1967, Dec-23, Volume: 216, Issue:5121 Topics: Amines; Brain; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Research; Schizophreni	1967
Harmful aspects of the LSD experience. The Journal of nervous and mental disease, 1967, Volume: 145, Issue:6 Topics: Adolescent; Adult; Depression; Drug Tolerance; Female; Humans; Lysergic Acid Diethylamide; Male; Mid	1967
Sleep in schizophrenia and depression--studies of sleep loss in man and animals. Research publications - Association for Research in Nervous and Mental Disease, 1967, Volume: 45 Topics: Aged; Animals; Brain; Brain Chemistry; Depression; Dopamine; Electroencephalography; Eye Movements;	1967
Drugs, biochemistry, and conscious experience: toward a theory of psychopharmacology. Perspectives in biology and medicine, 1984,Autumn, Volume: 28, Issue:1 Topics: Adaptation, Psychological; Animals; Catecholamines; Cognition; Depression; Dopamine; Humans; Lysergi	1984
Treating psychosomatic disorders related to birth trauma. Journal of psychosomatic research, 1978, Volume: 22, Issue:4 Topics: Abreaction; Birth Injuries; Depression; Dermatitis, Atopic; Female; Humans; Labor, Obstetric; Lyserg	1978
Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. Journal of neural transmission, 1979, Volume: 46, Issue:2 Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Humans; Kinetics; Lysergic Acid Diethy	1979
Problems and treatment of drug abuse in adolescence. Proceedings of the Royal Society of Medicine, 1975, Volume: 68, Issue:9 Topics: Adolescent; Amphetamine; Cannabis; Depression; Family Characteristics; Female; Guilt; Humans; Identi	1975
L.S.D. in psychiatry. Lancet (London, England), 1970, Nov-21, Volume: 2, Issue:7682 Topics: Depression; Humans; Lysergic Acid Diethylamide; Male	1970
Propranolol for L.S.D.-induced anxiety states. Lancet (London, England), 1971, Volume: 2, Issue:7732 Topics: Anxiety Disorders; Depression; Humans; Lysergic Acid Diethylamide; Male; Propranolol; Psychoses, Sub	1971
Focal suicide: self-enucleation by two young psychotic individuals. The American journal of psychiatry, 1972, Volume: 128, Issue:8 Topics: Abortion, Therapeutic; Adolescent; Adult; Anxiety, Castration; Bible; Cannabis; Delusions; Depressio	1972
Social and psychological factors associated with length of stay in a drug treatment facility. The International journal of the addictions, 1974, Volume: 9, Issue:6 Topics: Age Factors; Cannabis; Crime; Depression; Ethnicity; Heroin Dependence; Humans; Intelligence Tests;	1974
The psychology of hallucinogenic drug discontinuers. The American journal of psychiatry, 1972, Volume: 129, Issue:6 Topics: Adult; Anxiety; Depression; Female; Gambling; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mal	1972
Mind and body in biological psychiatry. Biological psychiatry, 1973, Volume: 5, Issue:3 Topics: Adult; Affect; Carbon Dioxide; Chlorpromazine; Conditioning, Classical; Depression; Desipramine; Ere	1973
[Configural frequency analysis. VI. Profile changes and symptom displacement]. Zeitschrift fur klinische Psychologie und Psychotherapie, 1973, Volume: 21, Issue:2 Topics: Adolescent; Adult; Depression; Female; Humans; Intelligence; Intelligence Tests; Lysergic Acid Dieth	1973
Depersonalization and the use of LSD: a psychodynamic study. American journal of psychoanalysis, 1972, Volume: 32, Issue:1 Topics: Adolescent; Aggression; Anxiety Disorders; Attitude; Body Image; Cognition Disorders; Conflict, Psyc	1972
The alienated, older, isolated male adolescent. American journal of psychotherapy, 1972, Volume: 26, Issue:3 Topics: Adult; Aggression; Anxiety; Cannabis; Depression; Humans; Interpersonal Relations; Lysergic Acid Die	1972
Dynamics of psychedelic drug abuse. A clinical study. Archives of general psychiatry, 1967, Volume: 16, Issue:5 Topics: Adult; Anxiety; Delirium; Depression; Hallucinogens; Humans; Intelligence Tests; Interpersonal Relat	1967
Complications of therapy with lysergide. Canadian Medical Association journal, 1969, Nov-29, Volume: 101, Issue:11 Topics: Adolescent; Adult; Affective Symptoms; Aged; Alcoholism; Cognition Disorders; Depression; Female; Hu	1969
The experimental use of psychedelic (LSD) psychotherapy. JAMA, 1970, Jun-15, Volume: 212, Issue:11 Topics: Alcoholism; Breast Neoplasms; Chromosome Aberrations; Depression; Female; Humans; Lysergic Acid Diet	1970
Depersonalization phenomena in psychiatric patients. The British journal of psychiatry : the journal of mental science, 1970, Volume: 117, Issue:540 Topics: Adolescent; Adult; Age Factors; Anomie; Anxiety; Autistic Disorder; Deja Vu; Depersonalization; Depr	1970
A comparison of short-term treatment effects of intravenous sodium amytal-methedrine and LSD in the alcoholic. Canadian Psychiatric Association journal, 1970, Volume: 15, Issue:5 Topics: Affect; Alcoholism; Amobarbital; Anxiety; Canada; Depression; Hallucinations; Humans; Injections, In	1970
Amphetamines, barbiturates, LSD and cannabis: their use and misuse. Reports on public health and medical subjects, 1970, Volume: 124 Topics: Amphetamine; Barbiturates; Cannabis; Child Behavior Disorders; Crime; Depression; Humans; Hyperkines	1970
[Complications caused by anonymous preclinical medication]. Arzneimittel-Forschung, 1970, Volume: 20, Issue:7 Topics: Amitriptyline; Antidepressive Agents; Barbiturates; Bromides; Cannabis; Chlordiazepoxide; Delirium;	1970
Unilateral ECT. (One year's experience at a city hospital). Diseases of the nervous system, 1971, Volume: 32, Issue:6 Topics: Adult; Bipolar Disorder; Dementia; Depression; Electroconvulsive Therapy; Female; Humans; Lysergic A	1971
Creatine kinase and aldolase in serum: abnormality common to acute psychoses. Science (New York, N.Y.), 1968, Mar-22, Volume: 159, Issue:3821 Topics: Anxiety; Bipolar Disorder; Catatonia; Clinical Enzyme Tests; Creatine Kinase; Depression; Fructose-B	1968
Characteristics of drug abusers admitted to a psychiatric hospital. JAMA, 1968, Jul-15, Volume: 205, Issue:3 Topics: Adult; Age Factors; Amphetamine; Antisocial Personality Disorder; Antitussive Agents; Barbiturates;	1968
[Psychopharmacologic drugs and prevention of suicide]. Wiener medizinische Wochenschrift (1946), 1968, May-18, Volume: 118, Issue:20 Topics: Adult; Age Factors; Antidepressive Agents; Bipolar Disorder; Depression; Humans; Lysergic Acid Dieth	1968
Hallucinations associated with pentazocine. The New England journal of medicine, 1969, Aug-21, Volume: 281, Issue:8 Topics: Adult; Depression; Female; Hallucinations; Humans; Injections, Intramuscular; Lysergic Acid Diethyla	1969
Suicide among college students. The American journal of psychiatry, 1969, Volume: 126, Issue:2 Topics: Adolescent; Adult; Competitive Behavior; Depression; Educational Measurement; Female; Humans; Identi	1969
[The treatment of a suicidal patient with LSD-25]. Nederlands tijdschrift voor geneeskunde, 1969, Aug-23, Volume: 113, Issue:34 Topics: Adult; Depression; Humans; Lysergic Acid Diethylamide; Male; Suicide Prevention	1969